Dianthus Therapeutics Inc (DNTH) returns
Dianthus Therapeutics returns over 3 years
$1,000 invested in Dianthus Therapeutics three years ago was worth $6,882 at the close on October 30, 2026, with dividends reinvested: an average return of 90.2% a year. The same $1,000 in the S&P 500 (SPY) became $1,885.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -6.4% | — | $935.61 | -0.9% |
| 3 months | -26.9% | — | $731.36 | +2.1% |
| Year to date | +99.9% | — | $1,999 | +11.7% |
| 1 year | +144.2% | — | $2,442 | +12.4% |
| 3 years | +588.2% | +90.2% | $6,882 | +88.5% |
Dianthus Therapeutics return by calendar year
| Year | DNTH | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +99.9% | +11.7% | +88.2% |
| 2025 | +89.0% | +17.7% | +71.3% |
| 2024 | +109.6% | +24.9% | +84.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: DNTH financials
No forecast, no recommendation. This page describes Dianthus Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.